Activin and Inhibin

Cirsiliol is a potent and selective 5-lipoxygenase inhibitor and a competitive low affinity benzodiazepine receptor ligand.In VitroIn concentrations from 0.01 to 300 μM, cirsiliol causes concentration-dependent relaxation of rat isolated ileum.

Cirsiliol is a potent and selective 5-lipoxygenase inhibitor and a competitive low affinity benzodiazepine receptor ligand.In VitroIn concentrations from 0.01 to 300 μM, cirsiliol causes concentration-dependent relaxation of rat isolated ileum.

Cirsiliol is a potent and selective 5-lipoxygenase inhibitor and a competitive low affinity benzodiazepine receptor ligand.In VitroIn concentrations from 0.01 to 300 μM, cirsiliol causes concentration-dependent relaxation of rat isolated ileum.

Cirsiliol is a potent and selective 5-lipoxygenase inhibitor and a competitive low affinity benzodiazepine receptor ligand.In VitroIn concentrations from 0.01 to 300 μM, cirsiliol causes concentration-dependent relaxation of rat isolated ileum.

Cirsiliol is a potent and selective 5-lipoxygenase inhibitor and a competitive low affinity benzodiazepine receptor ligand.In VitroIn concentrations from 0.01 to 300 μM, cirsiliol causes concentration-dependent relaxation of rat isolated ileum.

Cirtuvivint (SM08502) is a potent and orally active CDC-like kinase (CLK) inhibitor. Cirtuvivint can be used for solid tumors research.In VitroCirtuvivint (SM08502) inhibits serine and arginine rich splicing factor (SRSF) phosphorylation and

Cirtuvivint (SM08502) is a potent and orally active CDC-like kinase (CLK) inhibitor. Cirtuvivint can be used for solid tumors research.In VitroCirtuvivint (SM08502) inhibits serine and arginine rich splicing factor (SRSF) phosphorylation and

Cirtuvivint (SM08502) is a potent and orally active CDC-like kinase (CLK) inhibitor. Cirtuvivint can be used for solid tumors research.In VitroCirtuvivint (SM08502) inhibits serine and arginine rich splicing factor (SRSF) phosphorylation and

cis-8，11，14-Eicosatrienoic Acid.

cis-8，11，14-Eicosatrienoic Acid.

cis-8，11，14-Eicosatrienoic Acid.

cis-ccc_R08 (compound 1) is a flavonoid derivative that can be used in the study of hepatitis B virus ( HBV ) infection. cis-ccc_R08 is a cccDNA (covalently closed circular DNA) inhibitor.Form:Solid.